NeuroBlu was created by Holmusk, a global data science and digital technology company on a mission to reimagine behavioral health and transform lives.
Holmusk's journey into behavioral health began with MindLinc, an electronic health record (EHR) system for behavioral health, designed by psychiatrists at Duke University School of Medicine. The gold standard of clinical workflows, MindLinc's 20 years of longitudinal data is one of the richest and largest clinical databases for behavioral health in the world.
We have spent years devoted to learning and testing how to advance the field of behavioral health evidence, through understanding the nuances of the field and the complexities of psychiatry data. This domain expertise, combined with advanced technical skills, drives our ability to generate insights with impact.
We launched NeuroBlu to make our powerful evidence engine accessible across the health ecosystem. NeuroBlu's data warehouse and underlying data engineering processes were built by experts with the aim of making NeuroBlu an indispensable part of behavioral health research, innovation, and care delivery.
NeuroBlu is constantly growing, with more data and broader capabilities.
Through data partnerships and expanded EHR system sources, NeuroBlu's data warehouse will double in volume to over 2 million patients by the end of 2022.
We are actively working to get our data to regulatory-grade quality, which would enable life sciences companies to generate evidence that can support regulatory submissions.
The analytics toolkit is regularly updated, with more code templates and new tools that support clinical trial design, data visualization, and more.
We aim to integrate novel types of data to show the full picture of behavioral health. This includes patient-reported outcomes, data from digital tools, and claims data.